Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06749522

Enrollment

150

Registered

2024-12-27

Start date

2024-02-28

Completion date

2025-03-01

Last updated

2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Fibrosis

Brief summary

Fatty liver is a condition in which fat builds up in liver. it is very common health issue.it is major public health problems in the world. there is particular concern because fatty liver causes mortality among patients. The incidence and prevalence of disease vary with time. Fibrosis is thickening of connective tissues which is usually as a result of injury and long term inflammation. Cirrhosis is severe scarring of liver which is caused by long term liver damage. The scar tissue replaces healthy tissues which leads to loss of liver function. The Objective of study is to look into radiographic features of fatty liver disease. The high resolution ultrasonography will give more detailed view of disease. The study inclued 150 participants.

Detailed description

The other liver conditions like fibrosis and cirrhosis are also examined and correlated with fatty liver disease. The CT and MRI are used to compare with HR ultrasonographic findings. Descriptive statistics and comparative statistics are used to interpret data.

Interventions

RADIATIONhigh resolution ultrasonography

to compare high resolution ultrasonography finings with other imaging modalities(CT and MRI)

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Confirmed diagnosis of fatty liver (steatosis), fibrosis, or cirrhosis. * Patient consent to undergo imaging and participate in the study.

Exclusion criteria

* Other Liver Diseases: Exclusion of patients with other significant liver conditions (e.g., viral hepatitis, autoimmune liver diseases) unless specified. * Pregnant women may be excluded due to imaging concerns. * Poor quality or incomplete imaging studies. * Presence of other severe systemic illnesses that could affect liver function or imaging. * Recent liver surgeries or invasive procedures that might affect imaging results

Design outcomes

Primary

Measure	Time frame	Description
CT	12 Months	CT used for the image comparision
MRI	12 Months	CT used for the image comparision

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026